Can a second booster dose be delayed in patients who have had COVID-19?
Individuals who were previously infected produced significantly more antibodies, more rapidly. This information could inform the prioritisation of vaccine administration.
Watch the video below to learn more
The Institute has consolidated a stream of academic research projects arising from the public-private partnership established in 2002 between Richmond Pharmacology and St George's University of London to generate funding for academic research.